Qingsong Health announced that its Board of Directors approved the consolidated financial report for the first quarter of 2026 on May 13. The cumulative operating revenue from January to March reached NT$304.6 million, with an operating profit of NT$24.4 million. The net profit attributable to the parent company's owners was NT$32.19 million, resulting in a basic earnings per share (EPS) of NT$0.49.